Cancer incidence and mortality patterns in europe: Estimates for 40 countries and 25 major cancers in 2018, Eur. J. Cancer, vol.103, pp.356-387, 2018. ,
Primary breast cancer: Esmo clinical practice guidelines for diagnosis, treatment and follow-up, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol./ESMO, vol.26, 2015. ,
Have all triple-negative breast cancer patients worse breast cancer-specific survival?, Breast, vol.36, 2017. ,
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis, Genes Dis, vol.5, pp.77-106, 2018. ,
Molecular signatures in breast cancer, vol.131, pp.135-146, 2017. ,
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc. Natl. Acad. Sci, vol.98, pp.10869-10874, 2001. ,
Molecular portraits of human breast tumours, Nature, vol.406, pp.747-752, 2000. ,
Breast cancer molecular stratification: From intrinsic subtypes to integrative clusters, Am. J. Pathol, vol.187, pp.2152-2162, 2017. ,
4th eso-esmo international consensus guidelines for advanced breast cancer (abc 4)dagger, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol./ESMO, vol.29, pp.1634-1657, 2018. ,
Current landscape of targeted therapies for hormone-receptor positive, her2 negative metastatic breast cancer, Front. Oncol, vol.8, 2018. ,
Cure in metastatic breast cancer, vol.11, pp.172-179, 2018. ,
Ten-year survival in women with primary stage iv breast cancer, Breast Cancer Res. Treat, vol.160, pp.145-152, 2016. ,
Avelumab, an anti-pd-l1 antibody, in patients with locally advanced or metastatic breast cancer: A phase 1b javelin solid tumor study, Breast Cancer Res. Treat, vol.167, pp.671-686, 2018. ,
Checkpoint blockade in the treatment of breast cancer: Current status and future directions, Br. J. Cancer, vol.119, pp.4-11, 2018. ,
Tumor microenvironment: Sanctuary of the devil, Cancer Lett, vol.368, pp.7-13, 2015. ,
Releasing the brake: Safety profile of immune check-point inhibitors in non-small cell lung cancer, Expert Opin. Drug Saf, vol.16, pp.573-585, 2017. ,
Checkpoint inhibitors in melanoma and early phase development in solid tumors: What's the future?, J. Transl. Med, vol.15, 2017. ,
Emerging ways to treat breast cancer: Will promises be met?, Cell. Oncol. (Dordr.), vol.41, pp.605-621, 2018. ,
Inflammation and cancer: Back to virchow?, Lancet, vol.357, pp.539-545, 2001. ,
Cancer-related inflammation and treatment effectiveness, Lancet Oncol, vol.15, pp.493-503, 2014. ,
Balancing immune response: Crosstalk between adaptive and innate immune cells during breast cancer progression, Breast Cancer Res, vol.9, 2007. ,
Tumor-related interleukins: Old validated targets for new anti-cancer drug development, Mol. Cancer, vol.16, 2017. ,
Insights into the role of il-32 in cancer, Semin. Immunol, 2018. ,
Il-1 drives breast cancer growth and bone metastasis in vivo, Oncotarget, vol.7, pp.75571-75584, 2016. ,
Potential therapeutic implications of il-6/il-6r/gp130-targeting agents in breast cancer, Oncotarget, vol.7, pp.15460-15473, 2016. ,
Il-17 signaling: The yin and the yang, Trends Immunol, vol.38, pp.310-322, 2017. ,
Role of interleukin (il)-17 and t-helper (th)17 cells in cancer, Biochem. Biophys. Res. Commun, vol.493, pp.1-8, 2017. ,
Ctla-8, cloned from an activated t cell, bearing au-rich messenger rna instability sequences, and homologous to a herpesvirus saimiri gene, J. Immunol, vol.150, pp.5445-5456, 1993. ,
Human il-17: A novel cytokine derived from t cells, J. Immunol, vol.155, pp.5483-5486, 1995. ,
Life before seventeen: Cloning of the il-17 receptor, J. Immunol, vol.187, pp.4389-4391, 2011. ,
Interleukin-17 and innate immunity in infections and chronic inflammation, J. Autoimmun, vol.60, pp.1-11, 2015. ,
Targeting the tumor microenvironment: The protumor effects of il-17 related to cancer type, Int. J. Mol. Sci, vol.17, 1433. ,
URL : https://hal.archives-ouvertes.fr/hal-01841211
A focus on il-17 targeting treatments in psoriasis, J. Dermatol. Res, vol.2, pp.1-5, 2016. ,
Biomarkers related to bullous pemphigoid activity and outcome, Exp. Dermatol, vol.26, pp.1240-1247, 2017. ,
Interleukin-17 induces ap-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity, Carcinogenesis, vol.34, pp.341-350, 2013. ,
Innate immune cell-produced il-17 sustains inflammation in bullous pemphigoid, J. Investig. Dermatol, vol.134, pp.2908-2917, 2014. ,
Integrating longitudinal serum il-17 and il-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome ,
Il-17: A promising therapeutic target for atherosclerosis, Int. J. Cardiol, vol.202, pp.930-931, 2016. ,
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines, J. Exp. Med, vol.183, pp.2593-2603, 1996. ,
Il-17s adopt a cystine knot fold: Structure and activity of a novel cytokine, il-17f, and implications for receptor binding, EMBO J, vol.20, pp.5332-5341, 2001. ,
A structural superfamily of growth factors containing a cystine knot motif, Cell, vol.73, pp.421-424, 1993. ,
Interleukin-17 family and il-17 receptors, Cytokine Growth Factor Rev, vol.14, pp.155-174, 2003. ,
A novel heterodimeric cytokine consisting of il-17 and il-17f regulates inflammatory responses, Cell Res, vol.17, pp.435-440, 2007. ,
Identification of an interleukin 17f/17a heterodimer in activated human cd4+ t cells, J. Biol. Chem, vol.282, pp.13447-13455, 2007. ,
Comparative and evolutionary analysis of the interleukin 17 gene family in invertebrates, PLoS ONE, vol.10, 2015. ,
Interleukin-17 family members and inflammation, Immunity, vol.21, pp.467-476, 2004. ,
Functional specialization of interleukin-17 family members, Immunity, vol.34, pp.149-162, 2011. ,
Il-17b: A new area of study in the il-17 family, Mol. Immunol, vol.90, pp.50-56, 2017. ,
Structure of the unique sefir domain from human interleukin 17 receptor a reveals a composite ligand-binding site containing a conserved alpha-helix for act1 binding and il-17 signaling, Acta Crystallogr. D Biol. Crystallogr, vol.70, pp.1476-1483, 2014. ,
Effect of il-17a blockade with secukinumab in autoimmune diseases, Ann. Rheum. Dis, vol.72, pp.116-123, 2013. ,
The human il-17f/il-17a heterodimeric cytokine signals through the il-17ra/il-17rc receptor complex, J. Immunol, vol.181, pp.2799-2805, 2008. ,
Il-17ra and il-17rc receptors are essential for il-17a-induced elr+ cxc chemokine expression in synoviocytes and are overexpressed in rheumatoid blood, J. Immunol, vol.180, pp.655-663, 2008. ,
Identification of the il-17 receptor related molecule il-17rc as the receptor for il-17f, J. Immunol, vol.179, pp.5462-5473, 2007. ,
Interleukin 17 family cytokines: Signaling mechanisms, biological activities, and therapeutic implications, Cold Spring Harb. Perspect. Biol, vol.10, 2018. ,
Two types of murine helper t cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins, J. Immunol, vol.136, pp.2348-2357, 1986. ,
Il-17 is produced by some proinflammatory th1/th0 cells but not by th2 cells, J. Immunol, vol.162, pp.1246-1251, 1999. ,
A brief history of t(h)17, the first major revision in the t(h)1/t(h)2 hypothesis of t cell-mediated tissue damage, Nat. Med, vol.13, pp.139-145, 2007. ,
A distinct lineage of cd4 t cells regulates tissue inflammation by producing interleukin 17, Nat. Immunol, vol.6, pp.1133-1141, 2005. ,
Th17 cells: Effector t cells with inflammatory properties, Semin. Immunol, vol.19, pp.362-371, 2007. ,
Interleukin (il)-22 and il-17 are coexpressed by th17 cells and cooperatively enhance expression of antimicrobial peptides, J. Exp. Med, vol.203, pp.2271-2279, 2006. ,
Essential autocrine regulation by il-21 in the generation of inflammatory t cells, Nature, vol.448, pp.480-483, 2007. ,
The bench-to-bedside story of il-17 and the therapeutic efficacy of its targeting in spondyloarthritis, Curr. Rheumatol. Rep, vol.18, p.33, 2016. ,
Tgfbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of il-17-producing t cells, Immunity, vol.24, pp.179-189, 2006. ,
Harnessing the therapeutic potential of th17 cells, Med. Inflamm, 2015. ,
A validated regulatory network for th17 cell specification, Cell, vol.151, pp.289-303, 2012. ,
Il-17a secretion by cd8+ t cells supports th17-mediated autoimmune encephalomyelitis, J. Clin. Investig, vol.123, pp.247-260, 2013. ,
Toward an understanding of nkt cell biology: Progress and paradoxes, Annu. Rev. Immunol, vol.23, pp.877-900, 2005. ,
Thymic self-reactivity selects natural interleukin 17-producing t cells that can regulate peripheral inflammation, Nat. Immunol, vol.10, pp.1125-1132, 2009. ,
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain, Nature, vol.421, pp.744-748, 2003. ,
Human mast cells capture, store, and release bioactive, exogenous il-17a, J. Leukoc. Biol, vol.100, pp.453-462, 2016. ,
Mast cells and neutrophils release il-17 through extracellular trap formation in psoriasis, J. Immunol, vol.187, pp.490-500, 2011. ,
The il-23 to il-17 cascade inflammation-related cancers, Clin. Exp. Rheumatol, vol.33, pp.87-90, 2015. ,
Il-25 and il-33 contribute to development of eosinophilic airway inflammation in epicutaneously antigen-sensitized mice, PLoS ONE, vol.10, 2015. ,
Il-25 augments type 2 immune responses by enhancing the expansion and functions of tslp-dc-activated th2 memory cells, J. Exp. Med, vol.204, pp.1837-1847, 2007. ,
A tale of two cytokines: Il-17 and il-22 in asthma and infection, Expert Rev. Respir. Med, vol.8, pp.25-42, 2014. ,
Allergen-induced expression of il-25 and il-25 receptor in atopic asthmatic airways and late-phase cutaneous responses, J. Allergy Clin. Immunol, vol.128, pp.116-124, 2011. ,
Il-25 regulates th17 function in autoimmune inflammation, J. Exp. Med, vol.204, pp.161-170, 2007. ,
Il-17c regulates the innate immune function of epithelial cells in an autocrine manner, Nat. Immunol, vol.12, pp.1159-1166, 2011. ,
Expression of il-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients, Mol. Cells, vol.19, pp.180-184, 2005. ,
Cloning and characterization of il-17b and il-17c, two new members of the il-17 cytokine family, Proc. Natl. Acad. Sci, vol.97, pp.773-778, 2000. ,
Cutting edge: Il-17d, a novel member of the il-17 family, stimulates cytokine production and inhibits hemopoiesis, J. Immunol, vol.169, pp.642-646, 2002. ,
The multifaceted immune system, MOJ Immunol, vol.3, 2016. ,
Monoclonal antibodies targeting il-17a or its receptor in psoriasis: A new therapeutic approach?, Med. Sci, vol.28, pp.1035-1037, 2012. ,
Inflammatory breast cancer: An overview, Crit. Rev. Oncol./Hematol, vol.93, pp.116-126, 2015. ,
Il-17 expression by breast-cancer-associated macrophages: Il-17 promotes invasiveness of breast cancer cell lines, Breast Cancer Res, vol.10, 2008. ,
Il-17a is produced by breast cancer tils and promotes chemoresistance and proliferation through erk1/2. Sci ,
Interleukin-17, produced by lymphocytes, promotes tumor growth and angiogenesis in a mouse model of breast cancer, Mol. Med. Rep, vol.6, pp.1099-1102, 2012. ,
Cytokines related to mmp-11 expression by inflammatory cells and breast cancer metastasis ,
Il-17e synergizes with egf and confers in vitro resistance to egfr-targeted therapies in tnbc cells, Oncotarget, vol.7, pp.53350-53361, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01841201
Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17, Cancer Res, vol.68, pp.3915-3923, 2008. ,
Collagen induced arthritis increases secondary metastasis in mmtv-pyv mt mouse model of mammary cancer, BMC Cancer, vol.11, 2011. ,
Systemic neutralization of il-17a significantly reduces breast cancer associated metastasis in arthritic mice by reducing cxcl12/sdf-1 expression in the metastatic niches, BMC Cancer, vol.14, 2014. ,
Il-17a and its homologs il-25/il-17e recruit the c-raf/s6 kinase pathway and the generation of pro-oncogenic lmw-e in breast cancer cells ,
URL : https://hal.archives-ouvertes.fr/hal-01841216
The il-17b-il-17 receptor b pathway promotes resistance to paclitaxel in breast tumors through activation of the erk1/2 pathway, Oncotarget, vol.8, pp.113360-113372, 2017. ,
Cyclin e and survival in patients with breast cancer, The N. Engl. J. Med, vol.347, pp.1566-1575, 2002. ,
The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities, Int. J. Radiat. Oncol. Biol. Phys, vol.29, pp.243-247, 1994. ,
Autocrine/paracrine mechanism of interleukin-17b receptor promotes breast tumorigenesis through nf-kappab-mediated antiapoptotic pathway, Oncogene, vol.33, pp.2968-2977, 2014. ,
Il-17-producing gammadelta t cells and neutrophils conspire to promote breast cancer metastasis, Nature, vol.522, pp.345-348, 2015. ,
Il-25 blockade inhibits metastasis in breast cancer, Protein Cell, vol.8, pp.191-201, 2017. ,
Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development, PLoS ONE, vol.7, 2012. ,
Il-17e, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo, Cancer Immunol. Immunother, vol.59, pp.805-817, 2010. ,
Il-25 causes apoptosis of il-25r-expressing breast cancer cells without toxicity to nonmalignant cells, Sci. Transl. Med, 2011. ,
Il-17 inhibits the accumulation of myeloid-derived suppressor cells in breast cancer via activating stat3, Int. Immunopharmacol, vol.59, pp.148-156, 2018. ,
An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments, Cancer Res, vol.68, pp.3835-3843, 2008. ,
The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis, Mediat. Inflamm, 2014. ,
Interleukin-17 acts as double-edged sword in anti-tumor immunity and tumorigenesis, Cytokine, vol.89, pp.34-44, 2015. ,
Il-17 enhances the susceptibility of u-2 os osteosarcoma cells to nk cell lysis, Clin. Exp. Immunol, vol.133, pp.344-349, 2003. ,
Interleukin-17d mediates tumor rejection through recruitment of natural killer cells, Cell Rep, vol.7, pp.989-998, 2014. ,
Role of il-17 in glioma progression, J. Spine Neurosurg, pp.1-4, 2013. ,
The role of interleukin-17 in lung cancer, Mediat. Inflamm, vol.8494079, 2016. ,
Interleukin-17-induced emt promotes lung cancer cell migration and invasion via nf-kappab/zeb1 signal pathway, Am. J. Cancer Res, vol.5, pp.1169-1179, 2015. ,
Il-17a promotes the migration and invasiveness of cervical cancer cells by coordinately activating mmps expression via the p38/nf-kappab signal pathway, PLoS ONE, vol.9, 2014. ,
Interleukin 17, a t-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice, Cancer Res, vol.59, pp.3698-3704, 1999. ,
Interleukin-17 promotes angiogenesis by stimulating vegf production of cancer cells via the stat3/giv signaling pathway in non-small-cell lung cancer ,
Targeting the androgen receptor in prostate and breast cancer: Several new agents in development, Endocr. Relat. Cancer, vol.22, pp.87-106, 2015. ,
Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models, Cancer Res, vol.72, pp.2589-2599, 2012. ,
Interleukin-17 promotes prostate cancer via mmp7-induced epithelial-to-mesenchymal transition, Oncogene, vol.36, pp.687-699, 2016. ,
You, Z. Il-17 and insulin/igf1 enhance adhesion of prostate cancer cells to vascular endothelial cells through cd44-vcam-1 interaction, Prostate, vol.75, pp.883-895, 2015. ,
Interleukin-17 could promote breast cancer progression at several stages of the disease, Mediat. Inflamm, vol.804347, 2015. ,
A successful treatment with ustekinumab in a case of relapsing bullous pemphigoid associated with psoriasis, J. Eur. Acad. Dermatol. Venereol, vol.31, pp.228-230, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01825897